Strategic Partnerships Orfit actively collaborates with other leaders in radiation oncology and related fields, including recent partnerships with Leo Cancer Care. This presents an opportunity to approach joint procurement programs, co-branding opportunities, and bundled immobilization solutions for cancer treatment centers.

Expansion Signals Recent public activity highlights ESTRO 2026 participation and new collaboration announcements, indicating growth and openness to large-scale deployments. Engage with clinical and procurement teams at major radiotherapy centers to explore scalable immobilization and patient-positioning systems.

Innovative Materials Launch of SHAP3D a 3D printing filament for real-time adjustable hand therapy suggests a potential for expanding into customizable immobilization products and rapid prototyping services for rehab clinics and prosthetics centers.

Global Market Fit With a focus on thermoplastic materials for immobilization and mobilization across cancer care, orthotics, and prosthetics, Orfit serves a diverse medical device ecosystem. Target multi-site hospitals and rehab networks seeking reliable, precise positioning solutions.

Revenue Growth Potential Current revenue range indicates a mid-market profile. Building a tiered packaging of recurring consumables, service contracts, and training could create steady revenue streams with hospitals and clinics adopting standardized immobilization workflows.